In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...

Cases of a Victorian-era lung disease continue to rise in England and experts warn its growing resistance to antibiotics is a ...

Following the success of recent clinical trials, several major infectious disease agencies updated treatment guidance for ...

By Sharon AtienoThe price of pretomanid, the newest tuberculosis (TB) medicine, dropped to less than a dollar per day in April.The drug is now available through the Global Drug Facility (GDF) for ...

Study Finds Three New Safe, Effective Ways to Treat Drug-Resistant Tuberculosis Jan. 29, 2025 — Study finds three new safe and effective drug regimens to fight multidrug-resistant TB.

Mycobacteria are the world’s most deadly bacteria—causing infectious diseases including tuberculosis (TB), which alone kills ...

Global access to tuberculosis (TB) medicine pretomanid received a shot in the arm, as its price saw a 25% drop, thanks to a ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

TB Alliance applauds a new milestone in the fight against drug-resistant tuberculosis (DR-TB): a 25% price reduction for pretomanid, a key component of the BPaL/M regimens. Pretomanid is now available ...